This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Joint Stock Company "Biocad". Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Iana Andreevna Smirnova: Innovator in Biotechnology
Introduction
Iana Andreevna Smirnova is a prominent inventor based in Moscow, Russia. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. Her work is characterized by a commitment to advancing medical treatments through innovative research.
Latest Patents
Iana holds a patent for a monoclonal antibody that specifically binds to CD20. This invention relates to biotechnology and provides a monoclonal antibody that has the potential to be used in various therapeutic applications. The patent also encompasses DNA encoding the antibody, corresponding expression vectors, and methods of production, as well as treatment methods utilizing the antibody.
Career Highlights
Iana is currently employed at Joint Stock Company "Biocad," where she continues to push the boundaries of biotechnological research. Her work at Biocad has positioned her as a key player in the development of innovative medical solutions.
Collaborations
Iana collaborates with notable colleagues, including Pavel Andreevich Iakovlev and Natalia Eugenievna Pestova. These partnerships enhance her research efforts and contribute to the advancement of biotechnology.
Conclusion
Iana Andreevna Smirnova is a dedicated inventor whose work in biotechnology is paving the way for new medical treatments. Her innovative spirit and collaborative efforts are making a significant impact in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile